Bicalutamide Therapy Plus Radiation Improves PFS

Links shared publicly online about this topic.

380
total visits

Bicalutamide Therapy Plus Radiation Improves PFS

Bicalutamide during and after radiation therapy reduced the risk of progression and the risk of metastatic disease in men with a rising prostate-specific antigen

View full resource at onclive.com

Tags: Prostate Cancer Medication, Disease and Condition, Men's Health, Casodex, disease, Radiation

Most Recently Shared on April 8, 2011 at 2:11 pm By:

Editor

Bicalutamide during and after radiation therapy reduced the risk of progression in men with a rising PSA http://goo.gl/5DKyp

1 year ago...

Retweet

Favorite

March 2010, Vol. 33 No. 3 — The Cancer Letter

cancerletter.com — “Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer. Study Validates Use Of PCA3 Urine Test For Prostate Cancer. Phase III Study Finds Hormone Therapy Plus Radiation Improves Survival for Early Prostate Cancer. Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer. For Early Breast Cancer Spread To One Node, No Benefit Seen For Radiation. Few Breast Cancer Patients May Benefit From Contralateral Mastectomy, Study Says.” View full resource at cancerletter.com